A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization

被引:0
|
作者
Costello, MF [1 ]
Hughes, GJ [1 ]
Garrett, DK [1 ]
Hanjani, A [1 ]
Steigrad, SJ [1 ]
机构
[1] Royal Hosp Women, Dept Reprod Med, Sydney, NSW, Australia
关键词
controlled ovarian hyperstimulation; gonadotrophins; human menopausal gonadotrophin; clomiphene citrate; LH surge; unexplained infertility; human reproduction;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective-To determine whether a spontaneous luteinizing hormone (LH) surge influences the pregnancy and miscarriage rate in women with unexplained infertility undergoing controlled ovarian hyperstimulation (COH) without in vitro fertilization. Design-Retrospective cohort study. Setting-Ovulation Induction Clinic, Royal Hospital for Women, Sydney, Australia. Patients-145 patients with unexplained infertility who underwent 374 cycles of COH. Methods-Two types of ovarian stimulation protocols were used: human menopausal gonadotrophin (hMG) alone or hMG and clomiphene citrate (CC). A spontaneous LH surge occurred in 54% of the total cycles. All patients received human chorionic gonadotrophin, whether or not a spontaneous LH surge occurred. All cycles were covered by natural intercourse. Main Outcome Measures-Cycle pregnancy rate and miscarriage rate in cycles with or without a spontaneous LH surge. Results-The cycle pregnancy rate of the LH surge group was significantly higher than that of the no LH surge group for CC/hMG cycles (16.4% and 4.3% respectively, p = 0.02) but not for hMG alone cycles (12.8% and 10% respectively, P > .05). The miscarriage rate was not significantly different between the LH surge group and no LH surge group 11 either the CC/hMG cycles (30% and 75% respectively, P > .05) or the hMG alone cycles (22% and 38% respectively, P > .05). Conclusions-In women with unexplained infertility undergoing COH with CC/hMG, the occurrence of a spontaneous LII surge is a favorable event associated with a significantly increased pregnancy rate. The data showed a lower miscarriage rate, but there was insufficient power to confirm or refute this result.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 50 条
  • [1] Predictors of a spontaneous luteinizing hormone surge in controlled ovarian hyperstimulation cycles.
    Sproul, K.
    Huang, A.
    Landay, M.
    Trivax, B.
    Wu, J.
    DeCherney, A.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S176 - S177
  • [2] Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
    Zhu, Xiuxian
    Zhang, Xiaole
    Fu, Yonglun
    [J]. MEDICINE, 2015, 94 (21)
  • [3] Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
    Kuang, Yanping
    Chen, Qiuju
    Fu, Yonglun
    Wang, Yun
    Hong, Qingqing
    Lyu, Qifeng
    Ai, Ai
    Shoham, Zeev
    [J]. FERTILITY AND STERILITY, 2015, 104 (01) : 62 - +
  • [4] Beneficial use of ganirelix in controlled ovarian hyperstimulation (COH) cycles in older women undergoing in vitro fertilization (IVF).
    Jurema, MW
    Posada, MN
    Bracero, NJ
    Vlahos, NP
    Garcia, JE
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S130 - S130
  • [5] Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
    Escudero, EL
    Boerrigter, PJ
    Bennink, HJTC
    Epifanio, R
    Horcajadas, JA
    Olivennes, F
    Pellicer, A
    Simón, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04): : 2081 - 2088
  • [6] CONTROLLED OVARIAN HYPERSTIMULATION WITH OR WITHOUT INTRAUTERINE INSEMINATION FOR THE TREATMENT OF UNEXPLAINED INFERTILITY
    GREGORIOU, O
    VITORATOS, N
    PAPADIAS, C
    KONIDARIS, S
    GARGAROPOULOS, A
    LOURIDAS, C
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1995, 48 (01) : 55 - 59
  • [7] Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
    Haiyan Guo
    Yun Wang
    Qiuju Chen
    Weiran Chai
    Lihua Sun
    Ai Ai
    Yonglun Fu
    Qifeng Lyu
    Yanping Kuang
    [J]. Scientific Reports, 7
  • [8] Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
    Guo, Haiyan
    Wang, Yun
    Chen, Qiuju
    Chai, Weiran
    Sun, Lihua
    Ai, Ai
    Fu, Yonglun
    Lyu, Qifeng
    Kuang, Yanping
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Kahnberg, Annika
    Enskog, Anders
    Brannstrom, Mats
    Lundin, Kersti
    Bergh, Christina
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1373 - 1381
  • [10] The efficacy of medroxyprogesterone acetate (MPA) in women with endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
    Guo, H.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 251 - 251